Eli Lilly stock (LLY) edges higher after hours today as drug-pricing reset and January catalysts loom
Eli Lilly shares rose 0.5% to $1,080.36 in after-hours trading Friday after a volatile session. The move follows sector-wide drug price changes and renewed Washington scrutiny, with manufacturers planning 2026 list-price hikes. Investors are watching upcoming U.S. jobs and inflation data, as well as Lilly’s Jan. 13 conference appearance ahead of its Feb. 4 earnings report.